How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

This requires an algorithm: students are taught to stack one number atop another and multiply each digit of the bottom number ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

A new exoplanet model screens rocky worlds by their ability to retain atmospheres over geologic timescales, helping narrow the search for potentially habitable planets beyond Earth.

A study of 8.7M Google results finds review engagement correlates strongest with Local Pack visibility, with tactics varying by industry. In a world ruled by algorithms, SEJ brings timely, relevant ...

Vint Cerf speaks on stage at The 23rd Annual Webby Awards on May 13, 2019 in New York City. Noam Galai/Getty Images for Webby Awards Vint Cerf retired from Google on July 7 after 21 years as the ...